Stars Who’ve Spoken About GLP-1 Drugs — and What They’ve Said

People.com·2d ago

7 Best Online GLP-1 Programs of 2026 (Expert Approved)

Fortune·5d ago

GLP-1 drug coverage is being dropped by employer plans: What to know about 2027 weight-loss options

Coverage of GLP-1 drugs for weight loss is being dropped by many employer-sponsored healthcare plans as premiums soar, though workers have some new options.

CNBC·Oct 27

GLP-1 Drugs and Eating Disorders: What Research Shows About Benefits, Misuse, and Mental Health

The growing demand for GLP-1 drugs has raised concerns about potential misuse and the lack of evidence guiding their use outside approved indications.

News-Medical.Net·Oct 26

J.P. Morgan projeta US$ 22 bi em GLP-1 até 2035

O mercado de remédios GLP-1 no Brasil, na China e na Índia pode alcançar US$ 22 bilhões em 2035, partindo de US$ 6,6 bilhões, segundo projeção do J.P. Morgan citada pelo g1 com informações da Reuters.

SpaceMoney·Oct 23

How GLP-1 Travel Is Reshaping Hotels, Menus And Wellness

GLP-1 travel is changing hotels, from medication fridges and protein menus to wellness-led itineraries. See what travelers now expect.

Forbes·Oct 20

GLP-1 Costs: Semaglutide, Tirzepatide and Compounded GLP-1s Prices

Forbes·4d ago

Workers and researchers see benefits in GLP-1 access. Companies are weighing the costs

As GLP-1 use reaches new highs, more employers are grappling with whether the benefits of covering these medications justify their high costs.

CNBC·5d ago

Which Age Group Is Happiest Taking a GLP-1 Drug?

From access to satisfaction, GLP-1 drug usage differs among Gen Z, millennials, Gen X, and baby boomers. A new survey by Everyday Health highlights key trends in how different generations are using...

Everyday Health on MSN·Oct 27

GLP-1 Telehealth Red Flags: Signs It's Time to Switch Platforms

Watch out for GLP-1 telehealth red flags like instant prescriptions without medical screening, lack of direct access to a clinician and unclear compounding dosage instructions. Compare total monthly...

US News Health·Oct 26

GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says

The ​combined China-India-Brazil market for weight-loss drugs could grow to $22 billion by 2035 from $6.6 ‌billion currently, J.P. Morgan estimated, as improving affordability and broader access...

Reuters·Oct 23

GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD

Managed Healthcare Executive·Oct 19

Beauty Brands See a $30 Billion Opportunity in GLP-1s. The Product They're Selling Isn't New

Inc.com·4d ago

GLP-1 Lawsuits Raise Questions About Vision Loss and Other Serious Side Effects

MedShadow Foundation·6d ago

This Question Stops People From Trying a GLP-1

A new survey by Everyday Health identifies those most pressing issues to patients, from long-term weight maintenance to insurance coverage concerns and more. Dive into the results here.

Everyday Health·Oct 27

Taking a GLP-1 drug? Here's what the safety evidence really shows

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

News-Medical.Net·Oct 26

Comer menos, escolher melhor: como os GLP-1 mudaram o mercado de bens de consumo

Nossa entrevista com executivos da Worldpanel by Kantar revela como o avanço de medicamentos emagrecedores redefine o consumo no Brasil, impulsionando demanda por densidade nutricional, lácteos e...

MilkPoint·Oct 20

The GLP-1 access gap in type 2 diabetes isn’t coverage — it’s physician awareness | HSES 2026

Managed Healthcare Executive·Oct 19